Publications Database

Alvares G. A. , Quintana D. S. , Whitehouse A. J. (2017)

Beyond the hype and hope: Critical considerations for intranasal oxytocin research in autism spectrum disorder.

Autism Research

10 pp. 25–41.

Read Abstract (New Window) Read Full (New Window)

Anagnostou E. et al. (2012)

Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: a randomized controlled trial.

Molecular Autism

3(16),

Read Abstract (New Window) Read Full (New Window)

Cai Q. , Feng L. , Yap K. Z.

Systematic review and meta-analysis of reported adverse events of long-term intranasal oxytocin treatment for autism spectrum disorder.

Psychiatry and Clinical Neurosciences

Read Abstract (New Window)

Chan A. S. , Sze S. L. , Han Y. M. (2014)

An intranasal herbal medicine improves executive functions and activates the underlying neural network in children with autism.

Research in Autism Spectrum Disorders

June, 8(6), pp. 681-691.

Read Abstract (New Window)

DeMayo M. M. et al.

A review of the safety, efficacy and mechanisms of delivery of nasal oxytocin in children: Therapeutic potential for autism and Prader-Willi syndrome, and recommendations for future research.

Pediatric Drugs

Read Abstract (New Window)

Gordon I. et al. (2013)

Oxytocin enhances brain function in children with autism.

Proceedings of the National Academy of Science U S A

110(52), pp. 20953-20958.

Read Abstract (New Window) Read Full (New Window)

Keech B. , Crowe S. , Hocking D. R. (2018)

Intranasal oxytocin, social cognition and neurodevelopmental disorders: A meta-analysis

Psychoneuroendocrinology

87 pp. 9-19.

Read Abstract (New Window)

Lin I. et al. (2014)

The effect of intranasal oxytocin versus placebo treatment on the autonomic responses to human sounds in autism: a single-blind, randomized, placebo-controlled, crossover design study.

Molecular Autism

February, 5(1), 2.

Read Abstract (New Window) Read Full (New Window)

Munesue T. et al. (2016)

Oxytocin for male subjects with autism spectrum disorder and comorbid intellectual disabilities: A randomized pilot study.

Frontiers in Psychiatry

January,

Read Abstract (New Window) Read Full (New Window)

Quintana D. S. et al. (2017)

Dose-dependent social-cognitive effects of intranasal oxytocin.

Translational Psychiatry

May, 7(5), e. 1136.

Read Abstract (New Window)

Watanabe T. et al. (2014)

Mitigation of sociocommunicational deficits of autism through oxytocin-induced recovery of medial prefrontal activity: A randomized trial.

Journal of the American Medical Association

February, 71(2), pp. 166-175.

Read Abstract (New Window)